Clinical Trials: Acute Myelogenous Leukemia (AML)

Duarte : City of Hope Updated

A Phase I Study of 5-Fluoro-2-deoxycytidine with Tetrahydrouridine (FdCyd + THU) in Myeloid Leukemia and MDS

Duarte : City of Hope Updated New

Phase 2 Study of Clofarabine with High Dose Cytarabine and G-CSF Priminig in Adult Patients Less Than Age 65 with Newly Diagnosed Acute Myeloid Leukemia or Advanced Myelodysplastic Syndrome and/or Advanced Myeloproliferative Neoplasm

Various Cities : Research Center Updated

Acute Myeloid Leukemia - A2114

Tampa : Call for Information (Investigational Site 0006) Updated

Study of MK-8242 Alone and in Combination With Cytarabine in Participants With Acute Myelogenous Leukemia (P07649 AM2)

Various Cities : Research Center Updated

Acute Myeloid Leukemia - A2114

View More »

Chicago : Univerity of Chicago

Study of the Safety, Tolerability, Pharmacokinetics and Pharmacodynamic Properties of Oral AT-406 in Combination With Daunorubicin and Cytarabine in Patients With Poor-risk Acute Myelogenous Leukemia (AML)

Maywood : Loyola University, Cardinal Bernardin Cancer Center

Pilot Study Evaluating Safety & Efficacy of DCBT: NiCord® & UNM CBU to Patients With Hematological Malignancies

Baltimore : Call for Information (Investigational Site 0001) Updated

Study of MK-8242 Alone and in Combination With Cytarabine in Participants With Acute Myelogenous Leukemia (P07649 AM2)

Various Cities : Research Center Updated

Acute Myeloid Leukemia - A2114

View More »

Boston : Dana Farber Cancer Institute-Hematopoietic Stem Cell Transplant Program

Single Treatment With FT1050 of an Ex-vivo Modultated Umbilical Cord Blood Unit

Boston : Massachusetts General Hospital

Single Treatment With FT1050 of an Ex-vivo Modultated Umbilical Cord Blood Unit

Ann Arbor : University of Michigan Health System

Study of the Safety, Tolerability, Pharmacokinetics and Pharmacodynamic Properties of Oral AT-406 in Combination With Daunorubicin and Cytarabine in Patients With Poor-risk Acute Myelogenous Leukemia (AML)

St. Louis : Washington University at St. Louis Siteman Cancer Center

Study of the Safety, Tolerability, Pharmacokinetics and Pharmacodynamic Properties of Oral AT-406 in Combination With Daunorubicin and Cytarabine in Patients With Poor-risk Acute Myelogenous Leukemia (AML)

Durham : Duke University Medical Center

Pilot Study Evaluating Safety & Efficacy of DCBT: NiCord® & UNM CBU to Patients With Hematological Malignancies

Columbus : Ohio State Univeristy Comprehensive Cancer Center

Single Treatment With FT1050 of an Ex-vivo Modultated Umbilical Cord Blood Unit

Philadelphia : Hospital of the University of Pennsylvania

Study of the Safety, Tolerability, Pharmacokinetics and Pharmacodynamic Properties of Oral AT-406 in Combination With Daunorubicin and Cytarabine in Patients With Poor-risk Acute Myelogenous Leukemia (AML)

Philadelphia : Temple University at Jeanes Hospital

Study of the Safety, Tolerability, Pharmacokinetics and Pharmacodynamic Properties of Oral AT-406 in Combination With Daunorubicin and Cytarabine in Patients With Poor-risk Acute Myelogenous Leukemia (AML)

Houston : Call for Information (Investigational Site 0002) Updated

Study of MK-8242 Alone and in Combination With Cytarabine in Participants With Acute Myelogenous Leukemia (P07649 AM2)

Various Cities : Research Center Updated

Acute Myeloid Leukemia - A2114

Morgantown : West Virginia University - Clinical Trials Research Unit

BMTCTN0901: A Randomized, Multi-Center, Phase III Study of Allogeneic Stem Cell Transplantation Comparing Regimen Intensity in Patients with Myelodysplastic Syndrome or Acute Myeloid Leukemia

Morgantown : West Virginia University - Clinical Trials Research Unit

VOS-AML-301: A Phase 3, Randomized, Controlled, Double-Blind, Multinational Clinical Study of the Efficacy and Safety of Vosaroxin and Cytarabine Versus Placebo and Cytarabine in Patients With First Relapsed or Refractory Acute Myeloid Leukemia (VALOR)